Whitepapers/App Notes/Posters

Application Note: Microbiological considerations in cleanroom validation

Posted: 13 December 2018 | | No comments yet

Contamination, microbiological or otherwise, is a key safety concern in the development and manufacture of all pharmaceuticals and medical devices.

Ensuring that a product or device has been manufactured to all relevant pharmacopoeial regulations and is within any specified microbial limits is crucial when considering the effect of a contaminated product in the market.

Cleanrooms and other controlled environments play a vital role in manufacturing and testing processes through the control of airborne and surface contamination as the levels of particles allowed within these environments are strictly regulated.

Cleanroom grading systems are governed by a number of regulatory bodies and standard-setting organisations, with classification assessing the level of cleanliness of the environment against a specified range. 

The rest of this content is restricted - login or subscribe free to access

European Pharmaceutical Review Issue 3 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here